Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-940-4 | CAS number: 2014-83-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Oktober 1986 - November 1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 12 May 1981
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 2,6-dichlorobenzyl chloride
- EC Number:
- 217-940-4
- EC Name:
- 2,6-dichlorobenzyl chloride
- Cas Number:
- 2014-83-7
- Molecular formula:
- C7H5Cl3
- IUPAC Name:
- 2,6-dichlorobenzyl chloride
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - males approx 7 weeks old, females 8 weeks
- fed with Altromin 1234 ad libitum except that they are fasted 16 hours befor and 3 - 4 after application
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: sesame oil
- Doses:
- Dose finding: 1000 mg/kg BW, 3000 mg/kg BW, 5000 mg/kg BW
Main study: 1250 mg/kg BW, 2000 mg/kg BW, 3150 mg/kg BW - No. of animals per sex per dose:
- Dose finding: 1
Main study: 5 - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration
21 days, weekly weight check
- Necropsy of survivors performed: yes
All test animals were subjected to gross necropsy and result were recorded for each animal.
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other:
Impairment of locomotor system and breathing, narrowed to closed palpebral fissure, lacrimation, drooling, palpebral fissure and snout encrusted with blood, diarrhea, hyperemia, hypersensitivity against touch, shivering, spasm, daze feeling as well as genereally lowered state of health.
At higher doses also speraded hind legs, swaying motion. These findings were not reversible withing 21 days, histopatologic investigations showed selective degeneration of granule cells in cerebellum.
Dead animals showed petechial bleeding in stormach wall, diacnostic findings in pankreas, kidneys, liver and melt. No macroscopic visible obervation in animals that were sacrified at end of the study.
Body weight development of surviving animals was decreased withing the first week, after 14 days all animals exceeded their starting weight. - Statistics:
- probit analysis
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 100 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 120 mg/kg bw
- Based on:
- test mat.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 080 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 1250 mg/kg BW: 1/5 (male) and 0/5 (female)
2000 mg/kg BW: 2/5 (male) and 3/5 (female)
3150 mg/kg BW: 4/5 (male) and 4/5 (female) - Clinical signs:
- Impairment of locomotor system and breathing, narrowed to closed palpebral fissure, lacrimation, drooling, palpebral fissure and snout encrusted with blood, diarrhea, hyperemia, hypersensitivity against touch, shivering, spasm, daze feeling as well as genereally lowered state of health.
At higher doses also speraded hind legs, swaying motion. These findings were not reversible withing 21 days, histopatologic investigations showed selective degeneration of granule cells in cerebellum. - Body weight:
- Body weight development of surviving animals was decreased withing the first week, after 14 days all animals exceeded their starting weight.
- Gross pathology:
- Dead animals showed petechial bleeding in stormach wall, diacnostic findings in pankreas, kidneys, liver and melt. No macroscopic visible obervation in animals that were sacrified at end of the study.
Applicant's summary and conclusion
- Interpretation of results:
- other: STOT SE 2
- Conclusions:
- LD50 of 2,6-dichlorobenzyl chloride is 2100 mg/kg body weight after single oral administration to Wistar rats for both sexes.
While the substance is not classified as acute toxic, observation of irreversible damage in brain at 2000 mg/kg body weight and 3150 mg/kg body weight in the surviving animals leads to classification as STOT SE 2. - Executive summary:
The purpose of the study was to evaluate the potential toxic effect of the test item 2,6-dichlorobenzyl chloride when administered as a single oral dose to Wistar rats.
The procedure according to the OECD-Guidline 401 (Acute Oral Toxicity) was used. A prestudy using one male and female each was performed at 1000 mg/kg BW, 3000 mg/kg BW and 5000 mg/kg BW. At the lowest dose both animals survived, at the highest dose both died. At 3000 mg/kg BW the female died.
The doses in the main study were set as 1250 mg/kg BW, 2000 mg/kg BW and 3150 mg/kg BW. Deaths were as follows:
Dose [mg/kgBW] Death male Death female 1250 1/5 0/5 2000 2/5 3/5 3150 4/5 4/5 Animals were observed for 21 days after exposure, body weight was checked on weekly basis. After observation period all surviving animals were sacrified. Necropsy was performed.
The following clinical signs were observed:
Impairment of locomotor system and breathing, narrowed to closed palpebral fissure, lacrimation, drooling, palpebral fissure and snout encrusted with blood, diarrhea, hyperemia, hypersensitivity against touch, shivering, spasm, daze feeling as well as genereally lowered state of health.
At higher doses also speraded hind legs, swaying motion. These findings were not reversible withing 21 days, histopatologic investigations showed selective degeneration of granule cells in cerebellum.
Dead animals showed petechial bleeding in stormach wall, diacnostic findings in pankreas, kidneys, liver and melt. No macroscopic visible obervation in animals that were sacrified at end of the study.
Body weight development of surviving animals was decreased withing the first week, after 14 days all animals exceeded their starting weight.
LD50 was examined as 2100 mg/kg BW for both sexes, 2080 mg/kg BW for males, 2120 mg/kg BW for females. The substance is not classified as acute toxic but given the irreverible degeneration in animals brains, the substance is classified as STOT SE 2.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.